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MarylandABSTRACT It has been observed experimentally that cells from failing hearts exhibit elevated levels of reactive oxygen spe-
cies (ROS) upon increases in energetic workload. One proposed mechanism for this behavior is mitochondrial Ca2þ misman-
agement that leads to depletion of ROS scavengers. Here, we present a computational model to test this hypothesis. Previously
published models of ROS production and scavenging were combined and reparameterized to describe ROS regulation in the
cellular environment. Extramitochondrial Ca2þ pulses were applied to simulate frequency-dependent changes in cytosolic
Ca2þ. Model results show that decreased mitochondrial Ca2þuptake due to mitochondrial Ca2þ uniporter inhibition (simulating
Ru360) or elevated cytosolic Naþ, as in heart failure, leads to a decreased supply of NADH and NADPH upon increasing cellular
workload. Oxidation of NADPH leads to oxidation of glutathione (GSH) and increased mitochondrial ROS levels, validating the
Ca2þ mismanagement hypothesis. The model goes on to predict that the ratio of steady-state [H2O2]m during 3Hz pacing to
[H2O2]m at rest is highly sensitive to the size of the GSH pool. The largest relative increase in [H2O2]m in response to pacing
is shown to occur when the total GSH and GSSG is close to 1 mM, whereas pool sizes below 0.9 mM result in high resting
H2O2 levels, a quantitative prediction only possible with a computational model.INTRODUCTIONOxidative stress has been shown in patients experiencing
heart failure (HF) through elevated levels of biomarkers in
the bloodstream and pericardial fluid (1–3). In animal
models of HF, oxidative stress is also present and has been
proposed to be a consequence of both increased mitochon-
drial reactive oxygen species (ROS) production (4) and
decreased antioxidant capacity (5–7). Moreover, expression
of a mitochondrially targeted H2O2 scavenger enzyme, cata-
lase, has been shown to attenuate age-related cardiac
dysfunction, oxidative damage, and mortality (8).
Frequent changes in heart rate equating to changes in
cardiac workload require tight regulation of ATP supply
and demand. This regulation of ATP is carried out by
ADP and Ca2þ signals. Experimental data shows that
changes in [Ca2þ]i and [ADP]i induced by changes in pac-
ing frequency exert differing control on the mitochondrial
NADH redox state, sometimes referred to as push and
pull, respectively. Increases in cytosolic ADP (pull condi-
tions) are conveyed to the mitochondria via the adenine
nucleotide transporter and activation of the ATP synthase,
which stimulates the respiratory rate and oxidizes NADH.
At the same time, increased cytosolic Ca2þ transients
lead to increased mitochondrial Ca2þ via the mitochondrial
Ca2þ uniporter (mCU). Elevated mitochondrial Ca2þ stim-
ulates the Ca2þ-sensitive enzymes of the tricarboxylic acid
(TCA) cycle, leading to enhanced production of NADH.
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0006-3495/13/12/2832/11 $2.00homeostasis of NADH redox potential so that mitochon-
drial energy production can be maintained. NADH levels
in the mitochondrial matrix are linked to NADPH levels
through the proton-translocating transhydrogenase (THD).
Nicotinamide adenine dinucleotide phosphate (NADPH)
can also be produced in the matrix by the actions of the
NADPþ-dependent isocitrate dehydrogenase and malic
enzyme, two enzymes that also depend on TCA cycle inter-
mediates. NADPH plays a critical role in maintaining anti-
oxidant capacity through the NADPH-dependent enzymes
glutathione reductase (GR) and thioredoxin reductase
(TrxR), maintaining the reduced state of the glutathione
(GSH) and thioredoxin (Trx) antioxidant pools, which are
oxidized as a consequence of H2O2 scavenging by gluta-
thione peroxidase and peroxiredoxin, respectively.
[Ca2þ]m thus plays a key role in regulating mitochondrial
ROS scavenging through coupling between the generation
of redox equivalents for energy generation and the antiox-
idant pathways.
Cytosolic Naþ levels have been shown to be elevated in
HF (9–11), and contribute to mitochondrial ROS production
(12–14). Elevated cytosolic Naþ increases the rate of the
mitochondrial Naþ-Ca2þ exchanger (mNCE), which pro-
motes mitochondrial Ca2þ efflux and decreases the mito-
chondria’s ability to accumulate Ca2þ during pacing.
Without Ca2þ-induced TCA cycle stimulation, NADH and
NADPH become more oxidized and are unable to recharge
the antioxidant systems, which is hypothesized to lead to the
high ROS emission seen in HF cells at high pacing fre-
quencies (15). This proposed mechanism of energyhttp://dx.doi.org/10.1016/j.bpj.2013.11.007
Control of ROS in Heart Failure 2833insufficiency in HF emphasizes the importance of Ca2þ
signaling at the cellular and mitochondrial levels.
Previous work (16,17) has endeavored to demonstrate
the impact of variations in scavenging capacity on
observed ROS overflow from mitochondria. Although the
models furthered the understanding of the contribution
of ROS scavenging to ROS overflow, none of them
included a physiological model of ROS production.
Several models of ROS production exist (18–25), each
having various strengths and weaknesses. We recently
developed a model of ROS production (25) that con-
strained respiratory rate, electron transport chain (ETC)
redox state, and ROS production rates from complexes I
and III using experimental data. This model of ROS pro-
duction was chosen as a module for the model presented
here because of its extensive validation using experimental
data from cardiac mitochondria wherever possible. In this
work we combine detailed models of ROS scavenging and
ROS production to understand how these two mechanisms
control ROS levels in HF.METHODS
Model description
Fig. 1 depicts the components of the cardiac ROS production and scav-
enging pathways represented in the model. Briefly, the electron transport
chain with ROS production comes from the Gauthier et al. (25) electron
transport chain and reactive oxygen species (ETC-ROS) model. The only
modifications were scaling ROS production to agree with experimental
data in the absence of scavenging (16) and slight changes to complex I
for the cellular model (see the Supporting Material for details). ROS
scavenging was derived from the Kembro et al. (17) mitochondrial ener-
getic-redox (ME-R) model with some changes to parameters as noted in
the Supporting Material. Both of these models represent guinea pigMnSOD
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H+ H+ H+cardiac mitochondria and were fit to data from such preparations wher-
ever possible.Computational methods
The mitochondrial model introduced here consists of 37 nonlinear ordinary
differential equations. The equations were implemented in MATLAB 7.1
(The MathWorks, Natick, MA). Model parameters were optimized using
the fmincon function from MATLAB. For the protocols described, the
model was run from steady-state resting initial conditions, when the magni-
tude of each time derivative was %105 mM/ms. Initial conditions are
given in the Supporting Material.Model integration
The ETC-ROS model was successfully incorporated into the ME-R
isolated mitochondria model with minimal changes. It was necessary
to add explicit dependence on succinate and malate and inhibition by
oxaloacetate to the equation for succinate dehydrogenase to couple the
enzyme to the TCA cycle. ROS production rates were scaled to match
those of the ME-R model. The behavior of isolated mitochondria is
often compared between state 4 respiration (energized with substrates,
but in the absence of ADP) and state 3 respiration (energized with sub-
strates in the presence of ADP) to deduce the effects of rapid respiration
rates associated with ATP production in state 3. A comparison of state 4
and state 3 steady-state behaviors from experimental data, the ME-R
model, and the combined ME-R and ETC-ROS model are presented in
Table 1.
A significant achievement of this model is that ROS production is
modulated between state 3 and state 4 without a change in the model pa-
rameters. This is also evident in Fig. S1 in the Supporting Material
showing the effect of inhibition of the GSH or Trx scavenging systems
in state 3 and state 4. The present model maintains the proportional con-
trol established by Kembro et al. (17) such that inhibition of the Trx sys-
tem leads to higher H2O2 emission fluxes than inhibition of the GSH
system, as has been shown experimentally for guinea pig (17). The dy-
namics of the ME-R model were also maintained after incorporation of
















FIGURE 1 Overview of the mitochondrial
model, including ROS production and scavenging
pathways. The model presented here builds upon
the model of Kembro et al. (17) by incorporating
a detailed, mechanistic model of the ETC (gray
box) by Gauthier et al. (25) that determines respira-
tory and superoxide production fluxes. The com-
bined model features mechanistic ROS production
from the ETC, mitochondrial matrix scavenging,
transport of H2O2 across the inner mitochondrial
membrane, extramitochondrial scavenging,
NADH, and NADPH production by the TCA cycle,
NADþ/NADH and NADPþ/NADPH interconver-
sion by THD, and mitochondrial ion handling.
For simulations of cellular behavior, the extramito-
chondrial space represents the cytosol. See the
Supporting Material for specific parameter
changes. To see this figure in color, go online.
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TABLE 1 Quantitative comparison of energetic measurements in the absence of scavenging
Variable
Experimental Kembro et al. model New model
St 4 St 3 St 4 St 3 St 4 St 3
Respiration (nmol/mg protein/min) 465 2.6 1525 8.5 27.92 58.52 34.78 59.41
H2O2 emission (nmol/mg protein/min) 0.565 0.01 0.485 0.06 0.48 0.46 0.2582 0.1949
H2O2 emission as % of respiratory flux 0.74 0.29 1.7 0.78 0.74 0.33
DJm (mV) 1675 7 1425 2 192.5 168 194.5 168.9
NADH (%) 985 4 785 5 96.5 61.3 94.6 65.2
Energetic and ROS-related measurements are compared across experimental data from Aon et al. (16), the Kembro et al. model (17), and the model presented
here. For simulations state 4 ADP ¼ 0.01 mM and state 3 ADP ¼ 1.0 mM. Kembro et al. (17) data were simulated from code supplied by the authors. The
shunt value for that code was 0.018 for state 4 and 0.008 for state 3. A scale factor of 2  60e3 was used to convert from mM/ms to nmol/min/mg protein.
2834 Gauthier et al.ADP addition protocols before and after the incorporation of the ETC-
ROS model.Parameter fitting for mitochondrial model in the
myocyte
The ROS scavenging model introduced in Kembro et al. (17) was origi-
nally parameterized to reproduce steady-state ROS emission data from
isolated mitochondria. To reproduce kinetic data on ROS emission
from isolated myocytes, some parameters were refit. Isocitrate dehydro-
genase NADPþ (IDH2) was refit using in vitro parameters from Popova
et al. 2007 (26). The random bi-bi enzyme kinetics model describing the
activity of the THD based on the randomly ordered binding of two sub-
strates and the randomly ordered unbinding of two products presented in
Kembro et al. (17) was modified to satisfy the thermodynamic constraint
from Sazanov and Jackson (27). Kinetic parameters for glutathione
peroxidase were refit to improve GSH sensitivity as compared to GSH-
dependence data from Aon et al. 2010 (28) (their Fig. 10 D). The
Michaelis-Menten constant of glutathione reductase for NADPH was
increased to improve sensitivity over the range of observed NADPH
values in the model. Other model parameters were modified to better
represent the conditions of the mitochondria in isolated myocytes. Refer
to the Supporting Material for more details.uniporter block conditions is 2.7 higher after pacing than at rest compared to
Ru360 compared to control, but with faster kinetics. Note that panel (C) of si
Kohlhaas et al. (15) 90% reduction in mCU flux is used to simulate Ru360 app
Biophysical Journal 105(12) 2832–2842Stimulus protocols
During pacing, the mitochondrial model was subjected to changes of extra-
mitochondrial Ca2þ and ADP concentrations to simulate a change in ener-
getic workload stimulated by the increased demand for ATP during
contraction. [Ca2þ]i transients were simulated as rectangular pulses of
Ca2þ from a diastolic level of 0.1–1 mM with a width of 200 ms. Cytosolic
ADP was increased from a basal level of 0.1–1.0 mM with a time constant
of 2 min to simulate the energy consumption by the contractile machinery
in the cytosol. Isoproterenol was present in the experiments used for com-
parison to accelerate the increase of [Ca2þ]i transient peaks from rest to the
steady-state pacing value near 1 mM. The effects of isoproterenol were not
explicitly simulated in the model other than to use the 1 mM value for peak
cytosolic Ca2þ. For the myocyte model simulations, pH and mitochondrial
phosphate were held constant.RESULTS
Altered Ca2D regulation by Ru360 increases ROS
A comparison of model behavior from rest to 3Hz pacing,
with or without 90% uniporter block (to simulate Ru360,
a mCU blocker), is shown in Fig. 2, along with experimentalFIGURE 2 Ru360 inhibits Ca2þ uptake, de-
creases NADH supply, and increases H2O2 release
at high workloads. (A) Model cytosolic Ca2þ was
held constant at 0.1 mM before pacing and simu-
lated after the onset of pacing as 200 ms periodic
pulses of 1 mM from a resting level of 0.1 mM.
(B) Experimental [Ca2þ]i transients exhibit similar
values before pacing and after the addition of
isoproterenol. (C) Control [Ca2þ]m in the model
accumulates to over 0.3 mM for control (gray),
whereas uniporter block limits accumulation to
below 0.1 mM for the first 15 min of pacing (black).
(D) Fluorescence signal for [Ca2þ ]m shows similar
kinetics to model data. (E) In simulations, uni-
porter inhibition (black) results in more extensive
oxidation of NADH than for control (gray) result-
ing in 0.86 mMNADH after 15 min pacing for con-
trol compared to 0.77 mM for mCU inhibition. (F)
Experimental NADH for Ru360 (solid symbols) is
~80% oxidized during pacing with control NADH
(open symbols) recovering to levels higher than at
rest. (G) Although an increase in workload elevates
mitochondrial [H2O2] for both control (gray) and
uniporter block (black) simulations, ROS for
1.67 for control. (H) Experimental data also show elevated [H2O2] for
mulations shows a longer simulation. Experimental data reproduced from
lication in the model.
Control of ROS in Heart Failure 2835data for the same protocol from Kohlhaas et al. (15). For
control conditions, the onset of pacing increases cytosolic
transients (Fig. 2, A - model and B - experiment), which
leads to elevation of mitochondrial Ca2þ, as shown in the
model (Fig. 2 C, gray) and experiment (Fig. 2 D, open sym-
bols). However, if mitochondrial Ca2þ regulation is altered
by a decrease in mCU flux, mitochondrial Ca2þ uptake is
then severely compromised, as shown in the model (Fig. 2
C, black) and in experiment (of Fig. 2 D, solid symbols).
In the event of altered Ca2þ regulation, NADH control is
also compromised. In this case, there is no Ca2þ-induced
stimulation of the TCA cycle and NADH becomes oxidized,
as shown in the model (Fig. 2 E, black) and in experiment
(Fig. 2 F, solid). As in the experimental data (15) shown
in Fig. 2 F (open symbols), model control NADH levels
show only a small variation after the onset of pacing
(Fig. 2 E, gray). In contrast, simulations with mCU inhibi-
tion show a significant decline in NADH upon pacing
with little to no recovery (Fig. 2 E, black). Insufficient
NADH in the mCU inhibition protocol is associated with
increased H2O2 over control, as shown in the model
(Fig. 2 G) and in experiment (Fig. 2 H).
NADPH plays a critical role in the mitochondrial scav-
enging system. As NADH becomes oxidized after the onset
of pacing at 5 min (Fig. 2 E), THD transfers electrons from
NADPH to NADþ, thus decreasing NADPH levels as shown
in Fig. 3 A. For simulations with mCU block, the NADH
depletion during pacing is larger, leading to a more substan-
tial decrease in NADPH (Fig. 3 A, gray line). As NADPH
levels decrease, the rate of GR activity decreases and GSH
becomes more oxidized, as shown in Fig. 3 B. A similar
mechanism applies to TrxR and Trx (see Fig. S3), though
to a lesser degree. It is the decrease in GSH concentration
that links the oxidation of NADH to increased ROS releaseA
B
FIGURE 3 mCU inhibition prevents NADPH recovery after onset of pac-
ing, which depletes GSH. (A) Model simulations predict that NADPH is
~40% oxidized in the presence of 90% mCU inhibition (black), compared
to an approximate 20% decrease for control (gray). (B) Decreases in
NADPH drive oxidation of GSH, which is more extensive in the presence
of mCU inhibition. GSH redox potentials for mCU inhibition correspond
well with the range given in Fig. 10 of Aon et al. 2010 for ROS overflow
in isolated mitochondria.from the mitochondria. As GSH becomes oxidized, the
scavenging abilities of the mitochondria are decreased, lead-
ing to an accumulation of H2O2 in the matrix and a higher
rate of release into the cytosol. Note that the GSH redox
potentials at rest and during pacing predicted by the model
agree well with the 280–250 mV range of GSH redox
potential measured experimentally in isolated mitochondria
by Aon et al. (28) in response to a similar protocol in
which antioxidant depletion increases ROS release (their
Fig. 10 D).
Development of the isolated ETC-ROS model included
validation of steady-state ROS production against different
constant NADH levels and DJ values obtained from
experimental data in isolated mitochondria (25). Results
from this previous study show that ROS production in-
creases with DJ and with increased reduction of NADH.
After this model was incorporated into the dynamically
varying mitochondrial environment, Ca2þ and ADP tran-
sients were applied to simulate pacing. Immediately after
the onset of pacing, DJ and NADH decreased. The imme-
diate drop in both of these variables leads to an abrupt
decrease in ROS production with and without mCU inhibi-
tion, according to the model (Fig. 4). As mitochondrial
Ca2þ increases in control simulations, NADH production
is stimulated. Higher NADH concentrations increase the
activity of complex I of the ETC, which uses electrons
from NADH to reduce ubiquinone (Q) to ubiquinol
(QH2). As the total mitochondrial ubiquinone pool
(Q pool) becomes more reduced ROS production is
increased, leading to a new, to our knowledge, steady-state
level slightly above the resting rate. With decreased Ca2þ
stimulation of NADH production in the mCU inhibition
simulations, the extent of reduction of the Q pool is not
as great and steady-state ROS production remains lower
than at rest. To observe the increased ROS release for
Ru360 shown experimentally, the decrease in scavengingFIGURE 4 Control ROS production increases upon pacing, whereas
mCU inhibition causes decrease. Gray line is control and black line is
90% mCU block. For mCU block, DJ decreases more upon stimulation
than for control. DJ has more control over ROS production than NADH
in this model. The combination of these two factors and the different rates
at which they change also accounts for the complex kinetics between 5 and
10 min.
Biophysical Journal 105(12) 2832–2842
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2836 Gauthier et al.capacity (see Fig. 3) must outweigh the decrease in ROS
production (Fig. 4). This observation helps explain the
slow kinetics of model [H2O2]m accumulation under
mCU block. Even though GSH oxidation after the onset
of pacing reduces scavenging, the drop in ROS production
shown in Fig. 4 initially outweighs the decrease in scav-
enging. However, as GSH continues to oxidize (Fig. 3 B)
the decrease in scavenging begins to overcome the
decrease in ROS production, leading to the slow increase
in [H2O2]m shown in Fig. 2 G. C
FIGURE 6 Elevated [Naþ]i limits mitochondrial Ca
2þ uptake and de-
pletes scavengers. (A) Mitochondrial Ca2þ accumulation is blunted in the
presence of 15 mM [Naþ]i (black) compared to control (gray). (B)
15 mM [Naþ]i conditions (black) lead to increased GSH oxidation
compared to control (gray). (C) Elevated cytosolic Naþ (black) leads to
decreased ROS production compared to control (gray), similar to mCU in-
hibition results.Elevated [NaD]i alters Ca
2D regulation and
increases ROS
Cytosolic Naþ has been experimentally shown to be
elevated in both guinea pig models of HF (12) and myocar-
dium from failing human hearts (29). Kohlhaas et al. (15)
hypothesized that this may be a key factor in the increased
levels of ROS emission observed from myocytes isolated
from failing hearts. The mNCE produces a Ca2þ extrusion
flux that opposes influx through the mCU. In conditions of
elevated [Naþ]I, the mNCE rate increases, counteracting
the mCU flux and leading to an overall result similar to
the block of mCU by Ru360.
Fig. 5 shows simulation results for elevated cytosolic Naþ
compared with experimental results from (15). For control
cells, 60 min after the onset of 3Hz pacing, mitochondrial
H2O2 levels increased 67% in the model (Fig. 5 A, gray)
compared to a 67% increase after 20 min observed in exper-
iments (Fig. 5 B, open symbols). For cells with cytosolic
Naþ increased to 15 mM, model simulations show a 115%
increase in [H2O2]m after 60 min (Fig. 5 A, black) compared
to 148% over 20 min in experiment (Fig. 5 B, solid sym-
bols). Similar to the mCU inhibition intervention, 15 mM
[Naþ]i leads to compromised mitochondrial Ca
2þ handling
and decreased scavenging capacity (Fig. 6, A and B, and
Fig. S4), which in turn leads to increased mitochondrialFIGURE 5 Elevated [Naþ]i increases ROS levels. (A) Model cytosolic
Naþ was increased from a control level of 5 mM (gray) to 15 mM (black),
within the range associated with HF. After the onset of 3Hz pacing at 5 min,
both simulations show elevated [H2O2]m, though high Na
þ continues to in-
crease beyond the steady state for control. (B) Experimental data from
Kohlhaas et al. (15) show a quantitatively similar trend, though with faster
kinetics.
Biophysical Journal 105(12) 2832–2842H2O2. As in the case of mCU inhibition, for elevated
[Naþ]i, ROS production is also decreased after the change
in workload (Fig. 6 C).
Under the hypothesis that mNCE is the primary link be-
tween elevated [Naþ]I and altered mitochondrial Ca
2þ regu-
lation, inhibition of the mNCE is expected to restore some
degree of the control of ROS emission. Simulations were
performed with model [Naþ]I at 15 mM and mNCE flux
reduced by 85% to simulate application of CGP37157.
This decrease in mitochondrial Ca2þ export flux success-
fully counteracts the [Naþ]i-dependent increase and restores
[H2O2]m to control levels, as shown in Fig. 7 A. Fig. 7 BFIGURE 7 Block of mNCE with CGP reduces ROS overflow in high
[Naþ]i conditions. (A) Model simulations using 15 mM [Na
þ]i and 85% in-
hibition of mNCE flux to simulate CGP37157 block (dotted line) restore
[H2O2]m to control levels (gray line). 15 mM [Na
þ]i trend without
CGP37157 (black) is shown for comparison. Simulations were started
from rest with 3Hz pacing initiated at 5 min. (B) Experimental data in non-
failing cells (NF/Con), untreated failing cells (F/Con), and failing cells
treated with CGP37157 (F/CGP) shows a similar response. Panel B repro-
duced from (15).
Control of ROS in Heart Failure 2837shows experimental data from control and HF cells with or
without CGP37157 and demonstrates a similar effect.FIGURE 9 Dependence of ROS increase with pacing on mitochondrial
GSH pool size. For large pools of GSH (R1.9 mM) the increase in
[H2O2]m after onset of 3Hz pacing is <10%. As the mitochondrial GSH
pool decreases beyond 1.9 mM, pacing-induced ROS elevation increases
to a maximum of ~2.8 near 0.9 mM. For smaller pools than 0.9 mM,
resting [H2O2]m is significantly elevated such that pacing induces a smaller
increase.Increased GSH pool reduces ROS overflow
Many experiments investigating the role of oxidative stress
in ischemia have shown that addition of exogenous antiox-
idants, such as GSH, can ameliorate pathological symptoms
(30,31). This mechanism was tested in the model. Fig. 8
shows that, compared to a control total matrix GSH/GSSG
pool in the model of 1 mM, increasing the pool size by
25% and by 75% both result in a decrease of the ROS over-
flow associated with the increase in pacing frequency.
Mitochondrial H2O2 increases by 67% after pacing
compared to rest for control, 21.9% for 1.25 mM GSH
pool, and 10.5% for 1.75 mM GSH pool. ROS production
remains unchanged for the three protocols (not shown).
The quantitative comparison of the results in Fig. 8 shows
that the ROS overflow behavior of the model is very sensi-
tive to the size of the GSH pool. Further analysis over a
range of 0.5–mM GSH pool size shows that ROS overflow
is the most sensitive to changes in GSH pool size near
1 mM, which is the control size in the model (Fig. 9). For
pool sizes <0.9 mM, the relative increase in [H2O2]m
appears to decrease. This effect is derived largely from the
trend in resting [H2O2]m levels. Steady-state [H2O2]m at
rest increases slightly with decreasing GSH pool size until
the pool size drops below 0.9 mM, at which point resting
[H2O2]m increases almost exponentially with decreasing
pool size (see Fig. S5). This is indicative of GSH scavenging
capacity being increasingly compromised at rest. With
reduced available GSH scavenging capacity, the resting
[H2O2]m level is already high and the increase after pacing
represents a smaller relative increase. Such a comparison is
difficult to quantify experimentally because GSH is usually
applied to the extracellular medium, making it challenging
to determine how much GSH is transported into the cytosolFIGURE 8 Increasing mitochondrial GSH pool size reduces the effect of
increased workload in [H2O2]m. Simulations were started from rest with
3Hz pacing initiated at 5 min. Control (1 mM pool) is black, dark gray is
25% increase in pool size, and light gray is 75% increase. ROS production
for these different GSH cases is identical.and the mitochondrial matrix. In the context of a computa-
tional model, many protocols are available that are not
possible in an experimental setting.DISCUSSION
In this work, we have combined a detailed model of ROS
scavenging within the mitochondrial environment with a
validated model of ROS production from the mitochondrial
ETC. Together, the ROS production and scavenging compo-
nents provide a biophysically accurate representation of the
control of ROS levels in the mitochondria. This combined
mitochondrial model is able to reproduce i), state 3 and state
4 steady-state energetics values and the proportion of respi-
ratory flux diverted to ROS, ii), the proportional control of
GSH and Trx systems on mitochondrial ROS emission,
and iii), the magnitude and kinetics of DJ and NADH dur-
ing a transition protocol from state 0 to state 4 to state 3.
After these validation steps, some parameters of the model
were modified (see Methods) to better simulate a mitochon-
drion within the cellular environment. This model is able to
replicate cellular data describing i), NADH oxidation and
increased H2O2 emission for increased workload after
mCU inhibition, ii), NADH oxidation and increased H2O2
emission for increased workload with elevated cytosolic
Naþ, iii), effective reversal of elevated [Naþ]i effects by
CGP37157, and iv), decreased H2O2 emission for increased
GSH pool size.Model predictions
The similar fluorescence properties and disparity in size be-
tween the NADþ/NADH and NADPþ/NADPH pools, with
the NADþ/NADH pool estimated to be at least 4–7 larger
(32,33), lead to the measurement of an NAD(P)H signal that
is more closely representative of NADH than NADPH. AsBiophysical Journal 105(12) 2832–2842
2838 Gauthier et al.such, to the authors’ knowledge, the kinetics of NADPH
levels in the cardiac myocyte during workload transitions
have never been reported experimentally. The model pre-
sented here offers predictions of NADPH during such a pro-
tocol. These predictions are based on the use of in vitro
parameters from the experimental data to constrain the
rate of conversion of NADH to NADPH by THD and the
validation of NADH transients against experimental data
(see Fig. 2). The model predicts that although NADPH
may be more reduced than NADH at rest, as NADH levels
drop for the mCU inhibition and elevated [Naþ]i protocols,
NADPH becomes more oxidized than NADH and the GSH
and Trx scavenging systems become compromised. The
proton motive force (PMF)-dependence and reversibility
of the THD are key to this behavior; in well-energized mito-
chondria with ample TCA cycle capacity, the THD serves to
bolster the antioxidant defenses, but the same enzyme can
contribute to depletion of the NADPH pool when the rate
of NADH oxidation exceeds its production. Given that
model pH is held constant, PMF drops upon the increase
in workload associated with the onset of pacing. The for-
ward, NADPH-producing reaction of the THD is driven
by the free energy of the transfer of protons in the
direction of the PMF. As PMF decreases, the rate of the for-
ward reaction decreases. At the same time, the decrease in
mitochondrial Ca2þ drives an oxidation of NADH. The
model predicts that, although IDH and aKGDH both serve
as Ca2þ-sensitive NADH reductases, aKGDH plays a larger
part in NADH control. A 10% decrease in the rate of
aKGDH causes a further 3% oxidation in NADH after the
onset of pacing in the uniporter block protocol, whereas a
10% decrease in IDH activity does not cause a significant
change in NADH levels (not shown). The combined effects
of NADH oxidation and decrease in PMF lead to a reversal
of the THD and decrease in NADPH levels, which ulti-
mately drives the ROS overflow behavior.
Although GSH/GSSG redox potential can be measured
experimentally, the concentrations of GSSG and GSH are
more important in analyzing the enzyme kinetics of the
scavenging reactions. These concentrations are difficult to
ascertain from the redox potential without a precise mea-
surement of the size of the GSH pool, which has been esti-
mated to vary significantly across different energetic
conditions, including starvation and oxidative stress (34).
The model predicts that depletion of NADPH associated
with the oxidation of NADH causes an oxidation of GSH
from 0.88 mM at rest to 0.83 mM for control, 0.74 mM
for 90% mCU block, and 0.77 mM for high [Naþ]i during
the workload transition, which results in increased H2O2
emission for all protocols. Given the increasing adoption
of redox-sensing GFP probes (35,36), quantitative assess-
ment of GSH and GSSG levels in vivo should be possible
in the near future. A parametric study of total mitochondrial
GSH pool size in the model shows that the amount of in-
crease in H2O2 after onset of pacing is very sensitive toBiophysical Journal 105(12) 2832–2842the total amount of GSH and GSSG available for pools
near 1 mM. Gilbert (34) cites ~2.4 mM GSH pool in the
cytoplasm of rat heart cells and asserts that cytosolic and
matrix concentrations are approximately equal, based on
the amount of GSH localized to the matrix of rat liver mito-
chondria and the volumetric ratio of the cytoplasm and
mitochondrial matrix. This is in good agreement with
the measurement of 2.7 mM total cytoplasmic GSH by
Aon et al. (37). However, direct measurement of matrix
GSH in guinea pig heart cells by Stanley et al. (38) gives
a value between 1 and 1.5 mM total GSH. The model, which
uses a value of 1 mM, is in good agreement with the model.
The Trx and GSH scavenger pathways both make a major
contribution to cardiac mitochondrial ROS scavenging, and
their individual contributions vary to some extent with spe-
cies (16). Deficiencies in one pathway can be partially
compensated by the other pathway, but both depend on
NADPH supply. The present model not only allows one to
examine the independent behaviors of the two scavenger
pathways, but is the first, to our knowledge, to describe
how both are coupled to the pyridine nucleotide redox poten-
tial, the proton motive force, and mitochondrial oxidative
phosphorylation. Moreover, in addition to ROS scavenging,
the complex effects of these factors on ROS production are
taken into account by model. With respect to relative contri-
butions of Trx and GSH to ROS scavenging rates, Fig. 3 B
and Fig. S3 show the effects of pacing on the mitochondrial
scavenging systems of control cells and those with the mCU
inhibited. Both GSH and Trx show an approximate 15 mV
oxidation of their redox potentials for the mCU inhibition
case due to the dependence of both GR and TrxR on
NADPH. However, throughout these two protocols, ETrx re-
mains more negative than EGSH, reflecting a greater reducing
potential for Trx compared to GSH, as initially suggested by
the work of Aon et al. (16). Although some scavenging pa-
rameters differ between the mitochondrial and cellular
models presented here, the results of scavenging inhibition
for the mitochondrial model (Fig. S1) also support the
greater role of Trx. Aon et al. (16) used auranofin and dini-
trochlorobenzene to progressively inhibit the Trx and GSH
systems, respectively, in isolated mitochondria, but more
work will need to be carried out in myocytes to examine
the contribution of each scavenger pathway to global ROS
accumulation in the cell. Nonmitochondrial sources of
ROS must also be taken into consideration in future models.
Perhaps the most significant prediction arising from the
model results regards the changes in ROS production after
workload transition. Although a naive interpretation of the
increase in ROS after pacing for Ru360-incubated cells
might attribute it to an increase in ROS production, the
model results show that the increase in ROS levels occurs
by a decrease in ROS production and an even larger
decrease in ROS scavenging (Figs. 3 and 4). Future experi-
mental studies in antioxidant-depleted cells could help vali-
date this prediction.
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From experimental data, it is evident that ROS emission
levels from cardiac myocytes increase after an increase in
workload, but separating the role of ROS production from
the role of ROS scavenging presents a challenge. We expect
that ROS scavenging is compromised to some extent by the
oxidation of NADH. However, there is a wide array of
concomitant changes to ROS production and scavenging
that will produce the same overall ROS levels. The model
predicts that ROS production for the 90% mCU inhibition
and elevated [Naþ]i protocols will decrease after the
workload transition. The decrease in ROS production is
attributable to the effects of NADH oxidation and DJ depo-
larization that occur during ADP addition. This follows from
the mechanism of ROS Production used in the Gauthier et al.
(25) ETC model, which requires high mitochondrial mem-
brane potential and a highly reduced Q pool. ROS produc-
tion during pacing for mCU inhibition and high [Naþ]i
protocols is lower with respect to control because of the
more oxidized NADH pool for those protocols with compro-
mised Ca2þ handling, which results in a more oxidized
Q pool and less driving force for ROS production.
The ROS production mechanism from complex III in the
ETC-ROS model depends on the accumulation of an unsta-
ble semiquinone (SQ) on the cytosolic-side quinone bind-
ing site of complex III. The concentration of this SQ
builds up as the net flux through complex III’s Q cycle stag-
nates. Under physiological conditions, this occurs due to
elevated DJ, reducing the rate of electron transfer through
the membrane from complex III’s bL heme to its bH heme.
Both hemes become reduced, leading electrons to stagnate
upstream at the cytosolic SQ. The unpaired electron from
SQ seeks stability by escaping to reduce oxygen, forming
superoxide, a reactive oxygen species. Since the older
models of ROS production used as the basis for the ETC-
ROS model were developed, new mechanisms of ROS pro-
duction from complex III have been proposed (39,40).
These mechanisms do not rely on a high concentration of
cytosolic-side SQ and require the availability of a threshold
amount of ubiquinone to accept electrons in the reverse re-
action from reduced heme bL. This version of the model
corrects the legacy value of 10 mM total NADþ/NADH
pool from Magnus and Keizer (41) that was used in the
original Gauthier et al. model (25) by changing it to the
1 mM value used in Wei et al. (42) 1 mM total NADþ/
NADH pool yields better control of NADþ- and NADH-
dependent TCA cycle enzymes and is in good agreement
with the z0.82 mM mitochondrial NADþ þ NADH pool
size measured in the heart (43). With this updated value
of the total NADþ/NADH pool size, the accumulation of
cytosolic-side SQ is dramatically reduced compared to
Gauthier et al. (25). However, the ROS production model
used here still requires a highly reduced Q pool. It is
possible that incorporation of a different mechanism mightchange the workload-dependence of ROS production,
which is a topic for future investigation.Previous modeling and critique of the model
The model presented here builds on the well-validated scav-
enging network of Kembro et al. (17), but with dynamic
ROS production adapted from Gauthier et al. (25) that varies
with changes in the mitochondrial energetic state. Although
Gauthier et al. (25) demonstrated the interaction of their
ROS production model with a minimal model of scav-
enging, to the authors’ knowledge, the model presented
here is the first to combine dynamic ROS production and
scavenging, both controlled by mitochondrialDJ and redox
state. It is still important to note the existence of other ROS
production or scavenging models in the literature. Models
by Adimora et al. (44) and Antunes et al. (45) describe
dynamic ROS scavenging, but their analyses do not include
scavenging in the mitochondrial matrix or endogenous
H2O2. Detailed modeling of ROS production was performed
by Selivanov et al. (20–23) and Demin et al. (18,19), but
without taking into account the mitochondrial mechanisms
for degradation of ROS.
Achieving quantitative agreement between the model and
the experimental data is hindered by the inability to calibrate
experimental fluorescence signals representing some
signaling components and the inability to measure other
components at all. Q pool redox state is difficult to monitor
continuously, especially in a cellular preparation. The mech-
anism controlling ROS production changes after pacing
(described previously) might be counterintuitive, but poses
just one mechanism to explain the experimental observation
that ROS release from the mitochondria increases in control
cells as well as cells with compromised Ca2þ handling. The
ROS production component of the cellular model is difficult
to validate experimentally and would benefit from future
experimental protocols in cells depleted of both matrix
and cytosolic scavenging systems.
Much remains unknown about the mitochondrial envi-
ronment within the cell, though it is known that compart-
mentation and buffering of metabolites like ATP in the
extramitochondrial space differs in cellular preparations
compared to isolated mitochondria (46,47). Changes in
ATP, Pi, pH, and the protonmotive force will affect the other
ionic species of the mitochondria (Ca2þ, Naþ, H
þ) via the
mitochondrial ion circuits involving transporters like the
phosphate carrier, mNCE, and mitochondrial Naþ/Hþ
exchanger. The control of the ion circuits that was well fit
in the model of Wei et al. (42) (a precursor to the ME-R
model) was likely to be compromised at the high pacing fre-
quencies associated with stimulation of isolated myocytes.
For this reason, in this work, pH and [Pi]m were clamped
in the cellular simulations (see Methods). Additionally, it
is known that some aspects of control change with respect
to that of the isolated mitochondrion (48,49). As such, itBiophysical Journal 105(12) 2832–2842
2840 Gauthier et al.is likely that other processes are still unaccounted for in the
model. For example, the b-adrenergic activation employed
in the experiments of Kohlhaas et al. (15) might impact
complex I function and ROS production (50). Additionally,
secondary ROS effects, such as redox modulation of trans-
porters, and changes in the permeability of the inner mito-
chondrial membrane may play a role in the experimental
results observed. However, these more minor mechanisms
would not be expected to affect the overall qualitative trends
of the model or experimental results.
The mitochondrial effects of acute b-adrenergic stimula-
tion in cardiac myocytes have been historically most closely
studied via changes in Ca2þ signaling. The relatively recent
discovery of the mitochondrial A-kinase anchor protein has
focused new efforts on elucidating the phosphorylation-
dependent regulatory mechanisms of the mitochondria,
though the effects of direct protein kinase A (PKA) phos-
phorylation on mitochondria are still controversial (see
(51) for review). A mitochondrial isoform of PKA is
anchored to the outer mitochondrial membrane, where it is
activated by elevated cytosolic cAMP levels derived from
the addition of isoproterenol (52). Activated PKA phosphor-
ylates several targets involved in cell survival, steroid meta-
bolism, and oxidative phosphorylation (52). Although
signaling pathways related to the apoptotic cascade operate
on the timescale of several hours (53), cAMP-dependent
regulation of complex I activity (54) and complex IV activ-
ity (55) may be relevant at the timescale of the simulations
performed here. Phosphorylation pathways regulated by
kinases other than PKA have also been shown to regulate
mitochondrial KATP channels and the voltage-dependent
anion channel (56). This first study, to our knowledge,
shows the qualitative relationship of increased workload
and ROS overflow using on Ca2þ-mediated beta-adrenergic
changes, but the incorporation of mitochondrial phosphory-
lation pathways could pose an interesting direction for
future work.
The simulations presented here do not represent a compre-
hensive analysis of all the processes involved in HF. In addi-
tion to elevated cytosolic Naþ, myocytes from failing hearts
also exhibit decreased Ca2þ load in the sarcoplasmic reticu-
lum (57) and smaller cytosolic Ca2þ transients (58). Although
these mechanisms were not examined here, we hypothesize
that they would further contribute to reduced mitochondrial
Ca2þ uptake and depletion of ROS scavenging systems, exac-
erbating the elevated [Naþ]i effects examined here. These
additional aspects of the HF phenotype could pose interesting
directions for further study.CONCLUSION
The integration and adaptation of previously published, dy-
namic models of ROS production (25) and scavenging (17)
provides insight into the control of ROS levels in failing
myocytes. Disruption of normal Ca2þ handling either byBiophysical Journal 105(12) 2832–2842application of Ru360 or by elevated [Naþ]i, as in HF, leads
to oxidation of the mitochondrial ROS scavenging systems
upon increasing workload. Although the net effect is an in-
crease in ROS levels, the model predicts that ROS produc-
tion for compromised mitochondria decreases with an
increase in pacing frequency. The findings based on this
model confirm the hypothesis that cells with compromised
mitochondrial Ca2þ-handling have decreased scavenging
resources, leading to increased ROS emission after work-
load transitions. Results from the model also suggest further
experimental investigation into ROS production in the
whole myocyte.SUPPORTING MATERIAL
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